EUVIMEDEUVIMED entdecken
Crossref

State-Regulated Psychedelics on a Collision Course With FDA

Mason Marks

JAMA · 26.12.2023 · 330 (24) · 2337

DOI: 10.1001/jama.2023.24762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 26.12.2023. Verfasst von Mason Marks. Beteiligte Einrichtung: Project on Psychedelics Law and Regulation (POPLAR), Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Ca…. Hauptthemen laut MEDLINE: Hallucinogens, State Government, United States Food and Drug Administration. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint examines how US states are reforming legislation to allow access to psychedelics for therapeutic use, but federal laws consider these agents to be Schedule I drugs, and the discordance between state and federal law may create confusion and conflict.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensState GovernmentUnited States Food and Drug AdministrationUnited States

Substanzen

Hallucinogens

Autor:innen und Institutionen

  • Project on Psychedelics Law and Regulation (POPLAR), Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, Massachusetts.
  • Florida State University College of Law, Tallahassee.

Zitieren

APA

Marks, M. (2023). State-Regulated Psychedelics on a Collision Course With FDA. JAMA, 330(24), 2337. https://doi.org/10.1001/jama.2023.24762

Vancouver

Marks M. State-Regulated Psychedelics on a Collision Course With FDA. JAMA. 2023;330(24):2337. doi:10.1001/jama.2023.24762

BibTeX
@article{Marks2023,
  author = {Marks, Mason},
  title = {State-Regulated Psychedelics on a Collision Course With FDA},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {24},
  pages = {2337},
  doi = {10.1001/jama.2023.24762}
}
Kostenlos starten →